BENGALURU (Reuters) – Indian regulators have given emergency use authorization for an antibody drug cocktail developed by Roche and Regeneron to treat COVID-19, Roche’s local partner said on Wednesday.
(Reporting by Sachin Ravikumar in Bengaluru; Editing by Arun Koyyur)
